These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19710507)

  • 21. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macromolecular crowding converts the human recombinant PrPC to the soluble neurotoxic beta-oligomers.
    Huang L; Jin R; Li J; Luo K; Huang T; Wu D; Wang W; Chen R; Xiao G
    FASEB J; 2010 Sep; 24(9):3536-43. PubMed ID: 20400537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
    Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the prion protein in the internalization of α-synuclein amyloids.
    De Cecco E; Legname G
    Prion; 2018 Jan; 12(1):23-27. PubMed ID: 29308725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D 2 interacts with Human PrP(c) (90-231) and breaks PrP(c) oligomerization in vitro.
    Suenaga M; Hiramoto Y; Matsunaga Y
    Prion; 2013; 7(4):312-8. PubMed ID: 23857314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into early events in the aggregation of the prion protein on lipid membranes.
    Sanghera N; Swann MJ; Ronan G; Pinheiro TJ
    Biochim Biophys Acta; 2009 Oct; 1788(10):2245-51. PubMed ID: 19703409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins.
    Tsiroulnikov K; Rezaei H; Dalgalarrondo M; Chobert JM; Grosclaude J; Haertlé T
    Biochim Biophys Acta; 2006 Jul; 1764(7):1218-26. PubMed ID: 16777497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
    Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
    J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
    Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
    Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
    Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
    Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
    Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.
    Wang F; Wang X; Orrú CD; Groveman BR; Surewicz K; Abskharon R; Imamura M; Yokoyama T; Kim YS; Vander Stel KJ; Sinniah K; Priola SA; Surewicz WK; Caughey B; Ma J
    PLoS Pathog; 2017 Jul; 13(7):e1006491. PubMed ID: 28704563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The P's and Q's of cellular PrP-Aβ interactions.
    Westaway D; Jhamandas JH
    Prion; 2012; 6(4):359-63. PubMed ID: 22874673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.
    Macedo B; Sant'Anna R; Navarro S; Cordeiro Y; Ventura S
    Microb Cell Fact; 2015 Nov; 14():174. PubMed ID: 26536866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.